Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAC Bank of America	$34.37 -7.7%	$43.74	$33.67 ▼ $48.08	$261.32B	1.32	37.81 million shs	107.69 million shs
BMY Bristol-Myers Squibb	$55.32 -4.3%	$58.62	$39.35 ▼ $63.33	$112.52B	0.41	12.78 million shs	14.65 million shs
BRK.A Berkshire Hathaway	$740,564.89 -6.8%	$747,219.03	$596,000.00 ▼ $808,029.50	$1.07T	0.8	3,846 shs	1,531 shs
JPM JPMorgan Chase & Co.	$210.09 -8.1%	$254.71	$179.20 ▼ $280.25	$639.44B	1.01	9.48 million shs	27.14 million shs
MRK Merck & Co., Inc.	$81.48 -5.7%	$90.90	$81.04 ▼ $134.63	$205.83B	0.4	11.23 million shs	22.96 million shs
PFE Pfizer	$22.99 -5.4%	$25.87	$22.95 ▼ $31.54	$130.27B	0.67	39.46 million shs	79.83 million shs
WFC Wells Fargo & Company	$60.91 -7.2%	$74.93	$50.15 ▼ $81.50	$199.11B	1.02	17.26 million shs	31.03 million shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAC Bank of America	0.00%	-16.64%	-16.89%	-23.29%	-8.19%
BMY Bristol-Myers Squibb	0.00%	-7.95%	-7.99%	-2.21%	+6.00%
BRK.A Berkshire Hathaway	0.00%	-6.18%	-0.80%	+8.67%	+16.97%
JPM JPMorgan Chase & Co.	0.00%	-13.53%	-14.64%	-13.64%	+5.95%
MRK Merck & Co., Inc.	0.00%	-8.63%	-13.25%	-17.81%	-37.28%
PFE Pfizer	0.00%	-8.77%	-12.27%	-13.54%	-15.57%
WFC Wells Fargo & Company	0.00%	-13.85%	-16.08%	-14.58%	+6.62%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAC Bank of America	4.9807 of 5 stars	4.4	3.0	4.2	3.3	2.6	1.7	3.8
BMY Bristol-Myers Squibb	3.7017 of 5 stars	1.2	3.0	4.2	4.0	3.5	3.3	0.0
BRK.A Berkshire Hathaway	0.6821 of 5 stars	0.0	0.0	0.0	2.1	2.2	0.8	1.3
JPM JPMorgan Chase & Co.	4.8504 of 5 stars	3.3	5.0	4.2	2.1	2.6	2.5	2.5
MRK Merck & Co., Inc.	5 of 5 stars	4.3	5.0	5.0	3.9	2.6	3.3	3.8
PFE Pfizer	4.9674 of 5 stars	3.3	3.0	4.2	4.2	3.3	3.3	3.1
WFC Wells Fargo & Company	4.6561 of 5 stars	3.3	3.0	2.5	2.5	2.7	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAC Bank of America	2.83	Moderate Buy	$48.31	40.55% Upside
BMY Bristol-Myers Squibb	2.33	Hold	$57.86	4.59% Upside
BRK.A Berkshire Hathaway	0.00	N/A	N/A	N/A
JPM JPMorgan Chase & Co.	2.53	Moderate Buy	$254.83	21.30% Upside
MRK Merck & Co., Inc.	2.65	Moderate Buy	$117.12	43.73% Upside
PFE Pfizer	2.63	Moderate Buy	$31.92	38.86% Upside
WFC Wells Fargo & Company	2.60	Moderate Buy	$75.50	23.95% Upside

Current Analyst Ratings Breakdown

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/4/2025	BAC Bank of America	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$53.00 ➝ $50.00
4/4/2025	JPM JPMorgan Chase & Co.	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$268.00 ➝ $264.00
4/4/2025	WFC Wells Fargo & Company	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$86.00 ➝ $84.00
4/3/2025	BAC Bank of America	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$49.50 ➝ $43.50
4/3/2025	WFC Wells Fargo & Company	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$82.00 ➝ $73.50
4/2/2025	JPM JPMorgan Chase & Co.	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$285.00 ➝ $284.00
4/2/2025	WFC Wells Fargo & Company	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$85.00 ➝ $83.00
4/1/2025	BAC Bank of America	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$51.00 ➝ $48.00
4/1/2025	JPM JPMorgan Chase & Co.	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$273.00 ➝ $265.00
3/27/2025	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
3/24/2025	WFC Wells Fargo & Company	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$79.00

(Data available from 4/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAC Bank of America	$101.89B	2.56	$3.00 per share	11.45	$35.50 per share	0.97
BMY Bristol-Myers Squibb	$48.30B	2.33	$5.84 per share	9.48	$8.08 per share	6.85
BRK.A Berkshire Hathaway	$424.23B	2.51	$35,349.16 per share	20.95	$393,011.22 per share	1.88
JPM JPMorgan Chase & Co.	$169.44B	3.47	$17.33 per share	12.12	$116.13 per share	1.81
MRK Merck & Co., Inc.	$64.17B	3.21	$2.83 per share	28.82	$14.85 per share	5.49
PFE Pfizer	$63.63B	2.05	$3.60 per share	6.38	$15.81 per share	1.45
WFC Wells Fargo & Company	$82.30B	2.42	$5.69 per share	10.70	$48.79 per share	1.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAC Bank of America	$27.13B	$3.22	10.67	7.88	1.21	14.10%	10.29%	0.84%	4/15/2025 (Estimated)
BMY Bristol-Myers Squibb	-$8.95B	-$4.42	N/A	9.08	2.07	-18.53%	13.93%	2.46%	4/24/2025 (Estimated)
BRK.A Berkshire Hathaway	$96.22B	$61,913.91	9.97	∞	N/A	28.89%	6.94%	3.77%	N/A
JPM JPMorgan Chase & Co.	$58.47B	$19.74	10.64	10.82	2.83	20.96%	16.99%	1.31%	4/11/2025 (Estimated)
MRK Merck & Co., Inc.	$17.12B	$6.73	12.11	8.23	0.77	26.67%	45.35%	17.36%	4/24/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	16.31	7.59	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)
WFC Wells Fargo & Company	$19.72B	$5.38	11.32	8.87	1.18	15.73%	12.38%	1.04%	4/11/2025 (Estimated)

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/29/2025	N/A	PFE Pfizer	$0.67	N/A	N/A	N/A	$14.43 billion	N/A
4/24/2025	N/A	BMY Bristol-Myers Squibb	$1.55	N/A	N/A	N/A	$10.77 billion	N/A
4/24/2025	N/A	MRK Merck & Co., Inc.	$2.16	N/A	N/A	N/A	$15.59 billion	N/A
4/15/2025	N/A	BAC Bank of America	$0.80	N/A	N/A	N/A	$26.83 billion	N/A
4/11/2025	N/A	JPM JPMorgan Chase & Co.	$4.57	N/A	N/A	N/A	$43.62 billion	N/A
4/11/2025	N/A	WFC Wells Fargo & Company	$1.24	N/A	N/A	N/A	$20.82 billion	N/A
2/22/2025	Q4 2024	BRK.A Berkshire Hathaway	N/A	$10,102.08	N/A	$6,508.94	N/A	$94.92 billion
2/6/2025	Q4 2024	BMY Bristol-Myers Squibb	$1.47	$1.67	+$0.20	$0.04	$11.57 billion	N/A
2/4/2025	Q4 2024	MRK Merck & Co., Inc.	$1.85	$1.72	-$0.13	$1.48	$15.51 billion	$15.62 billion
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion
1/16/2025	Q4 24	BAC Bank of America	$0.77	$0.82	+$0.05	$0.82	$25.12 billion	$25.30 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAC Bank of America	$1.04	3.03%	+8.63%	32.30%	11 Years
BMY Bristol-Myers Squibb	$2.48	4.48%	+6.38%	N/A	17 Years
BRK.A Berkshire Hathaway	N/A	N/A	N/A	N/A	N/A
JPM JPMorgan Chase & Co.	$5.60	2.67%	+8.10%	28.37%	15 Years
MRK Merck & Co., Inc.	$3.24	3.98%	+5.73%	48.14%	14 Years
PFE Pfizer	$1.72	7.48%	+2.50%	121.99%	16 Years
WFC Wells Fargo & Company	$1.60	2.63%	+35.72%	29.74%	N/A

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/3/2025	BMY Bristol-Myers Squibb	quarterly	$0.62	4.14%	4/4/2025	4/4/2025	5/1/2025
3/18/2025	JPM JPMorgan Chase & Co.	quarterly	$1.40	2.38%	4/4/2025	4/4/2025	4/30/2025
1/28/2025	MRK Merck & Co., Inc.	quarterly	$0.81	3.32%	3/17/2025	3/17/2025	4/7/2025
1/29/2025	BAC Bank of America	quarterly	$0.26	2.23%	3/7/2025	3/7/2025	3/28/2025
1/28/2025	WFC Wells Fargo & Company	quarterly	$0.40	2.05%	2/7/2025	1/7/2025	3/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAC Bank of America	1.04	0.78	0.78
BMY Bristol-Myers Squibb	2.90	1.25	1.15
BRK.A Berkshire Hathaway	N/A	0.30	0.30
JPM JPMorgan Chase & Co.	1.24	0.88	0.89
MRK Merck & Co., Inc.	0.79	1.36	1.15
PFE Pfizer	0.63	1.00	0.73
WFC Wells Fargo & Company	1.07	0.86	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAC Bank of America	70.71%
BMY Bristol-Myers Squibb	76.41%
BRK.A Berkshire Hathaway	22.97%
JPM JPMorgan Chase & Co.	71.55%
MRK Merck & Co., Inc.	76.07%
PFE Pfizer	68.36%
WFC Wells Fargo & Company	75.90%

Insider Ownership

Company	Insider Ownership
BAC Bank of America	0.30%
BMY Bristol-Myers Squibb	0.09%
BRK.A Berkshire Hathaway	0.39%
JPM JPMorgan Chase & Co.	0.79%
MRK Merck & Co., Inc.	0.09%
PFE Pfizer	0.06%
WFC Wells Fargo & Company	0.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAC Bank of America	217,000	7.60 billion	7.65 billion	Optionable
BMY Bristol-Myers Squibb	34,300	2.03 billion	2.03 billion	Optionable
BRK.A Berkshire Hathaway	372,000	1.44 million	1.43 million	Not Optionable
JPM JPMorgan Chase & Co.	293,700	2.80 billion	2.77 billion	Optionable
MRK Merck & Co., Inc.	69,000	2.53 billion	2.53 billion	Optionable
PFE Pfizer	83,000	5.67 billion	5.66 billion	Optionable
WFC Wells Fargo & Company	238,000	3.27 billion	3.33 billion	Optionable

WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Headlines

Recent News About These Companies

Wells Fargo & Company (NYSE:WFC) Shares Bought by Ilmarinen Mutual Pension Insurance Co

April 6 at 7:18 AM | marketbeat.com

Wells Fargo & Company (NYSE:WFC) Shares Sold by Russell Investments Group Ltd.

April 6 at 7:18 AM | marketbeat.com

Grantham Mayo Van Otterloo & Co. LLC Lowers Stock Holdings in Wells Fargo & Company (NYSE:WFC)

April 6 at 6:32 AM | marketbeat.com

Wells Fargo & Company (NYSE:WFC) Stock Holdings Cut by Aviva PLC

April 6 at 6:31 AM | marketbeat.com

Wells Fargo & Company (NYSE:WFC) Shares Sold by Waterloo Capital L.P.

April 6 at 6:16 AM | marketbeat.com

1,009,085 Shares in Wells Fargo & Company (NYSE:WFC) Purchased by Resona Asset Management Co. Ltd.

April 6 at 5:49 AM | marketbeat.com

Truist Financial Lowers Wells Fargo & Company (NYSE:WFC) Price Target to $84.00

April 6 at 3:59 AM | americanbankingnews.com

JPMorgan Chase & Co. Has Lowered Expectations for Wells Fargo & Company (NYSE:WFC) Stock Price

April 6 at 3:23 AM | americanbankingnews.com

Wells Fargo & Company (NYSE:WFC) Shares Down 6.7% After Analyst Downgrade

April 6 at 2:13 AM | americanbankingnews.com

Seaport Res Ptn Brokers Increase Earnings Estimates for WFC

April 6 at 1:29 AM | americanbankingnews.com

Wells Fargo (NYSE:WFC) Sees 14% Weekly Drop As Activist Investors Push Sustainability Proposals

April 5 at 8:38 PM | finance.yahoo.com

Lobbying Update: $110,000 of TRANSDIGM GROUP INC. lobbying was just disclosed

April 5 at 7:20 PM | quiverquant.com

Truist Financial Issues Pessimistic Forecast for Wells Fargo & Company (NYSE:WFC) Stock Price

April 5 at 12:26 PM | marketbeat.com

Wells Fargo & Company (NYSE:WFC) Shares Down 6.7% on Analyst Downgrade

April 5 at 11:32 AM | marketbeat.com

What is Seaport Res Ptn's Forecast for WFC Q1 Earnings?

April 5 at 7:23 AM | marketbeat.com

3 Reasons Wall Street Is Backing Braze Stock Right Now (WFC)

April 5 at 7:00 AM | marketbeat.com

Prudential PLC Reduces Stake in Wells Fargo & Company (NYSE:WFC)

April 5 at 5:32 AM | marketbeat.com

Wells Fargo & Company (NYSE:WFC) Stock Price Down 8.5% After Analyst Downgrade

April 5 at 2:43 AM | americanbankingnews.com

A Closer Look at Bank Stocks & Tariff Worries

April 4 at 9:50 PM | zacks.com

What's Going On With Wells Fargo (WFC) Stock?

April 4 at 2:42 PM | benzinga.com

Will Wells Fargo (WFC) Beat Estimates Again in Its Next Earnings Report?

April 4 at 1:15 PM | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
5 Reasons the S&P 500 Could Rebound Strongly in 2025
By Thomas Hughes | April 3, 2025
View 5 Reasons the S&P 500 Could Rebound Strongly in 2025
AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
By Leo Miller | March 14, 2025
View AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Everything About Amazon Stock Signals a Buy—Time to Load Up?
By Sam Quirke | March 20, 2025
View Everything About Amazon Stock Signals a Buy—Time to Load Up?
Tesla Stock: Has the Mother of All Comebacks Begun?
By Sam Quirke | March 26, 2025
View Tesla Stock: Has the Mother of All Comebacks Begun?

WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Company Descriptions

Bank of America NYSE:BAC

$34.37 -2.85 (-7.65%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$34.17 -0.20 (-0.59%)

As of 04/4/2025 07:59 PM Eastern

Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, non-interest and interest-bearing checking accounts, and investment accounts and products; credit and debit cards; residential mortgages, and home equity loans; and direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, short-term investing options, and merchant services; working capital management solutions; debt and equity underwriting and distribution, and merger-related and other advisory services; and fixed-income and equity research, and certain market-based services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.

Bristol-Myers Squibb NYSE:BMY

$55.32 -2.50 (-4.32%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$54.75 -0.57 (-1.03%)

As of 04/4/2025 08:00 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Berkshire Hathaway NYSE:BRK.A

$740,564.89 -53,949.11 (-6.79%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$741,369.00 +804.10 (+0.11%)

As of 04/4/2025 04:01 PM Eastern

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. It provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. The company also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydro, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; and flooring, insulation, roofing and engineered, building and engineered components, paints and coatings, and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services; and recreational vehicles, apparel products, jewelry, and custom picture framing products, and alkaline batteries. Further, it manufactures castings, forgings, fasteners/fastener systems, and aerostructures; and seamless pipes, fittings, downhole casing and tubing, and various mill forms. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle apparel and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

JPMorgan Chase & Co. NYSE:JPM

$210.09 -18.60 (-8.13%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$211.64 +1.55 (+0.74%)

As of 04/4/2025 08:00 PM Eastern

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

Merck & Co., Inc. NYSE:MRK

$81.48 -4.91 (-5.68%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$81.50 +0.02 (+0.02%)

As of 04/4/2025 07:59 PM Eastern

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Pfizer NYSE:PFE

$22.99 -1.30 (-5.35%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$22.94 -0.05 (-0.22%)

As of 04/4/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Wells Fargo & Company NYSE:WFC

$60.91 -4.76 (-7.24%)

Closing price 04/4/2025 03:59 PM Eastern

Extended Trading

$60.86 -0.05 (-0.08%)

As of 04/4/2025 07:57 PM Eastern

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Earnings

Compare Dividends

Latest WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WFC, BMY, PFE, MRK, BAC, JPM, and BRK.A Company Descriptions

Bank of America NYSE:BAC

Bristol-Myers Squibb NYSE:BMY

Berkshire Hathaway NYSE:BRK.A

JPMorgan Chase & Co. NYSE:JPM

Merck & Co., Inc. NYSE:MRK

Pfizer NYSE:PFE

Wells Fargo & Company NYSE:WFC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools